These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 34106037)

  • 1. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
    Dubin C; Del Duca E; Guttman-Yassky E
    Expert Rev Clin Immunol; 2021 Aug; 17(8):835-852. PubMed ID: 34106037
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of biologics in atopic dermatitis.
    Wu J; Guttman-Yassky E
    Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kraft M; Worm M
    Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
    McGregor S; Farhangian ME; Feldman SR
    Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26428945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of the IL-13 pathway in skin inflammation.
    Tubau C; Puig L
    Expert Rev Clin Immunol; 2021 Jan; 17(1):15-25. PubMed ID: 33275064
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
    Silverberg JI; Kantor R
    Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma and Atopic Dermatitis: A Review of Targeted Inhibition of Interleukin-4 and Interleukin-13 As Therapy for Atopic Disease.
    Buzney CD; Gottlieb AB; Rosmarin D
    J Drugs Dermatol; 2016 Feb; 15(2):165-71. PubMed ID: 26885783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab for the treatment of adolescents with atopic dermatitis.
    Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
    Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging biologic and small molecule therapies for atopic dermatitis.
    Li R; Hadi S; Guttman-Yassky E
    Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Skin Barrier Abnormalities with IL4/13 Inhibitors and Jak Inhibitors in Atopic Dermatitis: A Systematic Review.
    Chatzigeorgiou I; Koumaki D; Vakirlis E; Papadimitriou I; Gregoriou S
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202657
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologics for Atopic Dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Therapies for Atopic Dermatitis: A Systematic Review.
    Zhou S; Qi F; Gong Y; Zhang J; Zhu B
    Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in atopic dermatitis.
    Li W; Man XY
    Immunotherapy; 2022 Oct; 14(14):1149-1164. PubMed ID: 36046941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New era of biologic therapeutics in atopic dermatitis.
    Guttman-Yassky E; Dhingra N; Leung DY
    Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopic Dermatitis Host and Environment Model: Revisiting Therapeutic Options.
    Lopes A; Sokolova A; Abreu C; Lopes C
    Eur Ann Allergy Clin Immunol; 2020 Jan; 52(1):4-14. PubMed ID: 31789489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis.
    Bieber T
    Allergy; 2020 Jan; 75(1):54-62. PubMed ID: 31230370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 and IL-13 Inhibition in Atopic Dermatitis.
    Matsunaga MC; Yamauchi PS
    J Drugs Dermatol; 2016 Aug; 15(8):925-9. PubMed ID: 27537991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.